International Precision Medicine Conference 2021

Date of Event:   2021-04-21 - 2021-04-23
Location:  Virtual

Medlab Clinical is proud to present at the International Precision Medicine Conference 2021, between the 21st and 23rd April 2021

Location - Virtual

 

Abstract Title : Pain: an opioid epidemic requiring a non-opioid alternative

 

Precision Medicine (PMED) once synonymous with cancer treatment now has potential in a vaster field including infectious diseases, mental health, and age-related illnesses. Whilst PMED holds such vast promise, current day “pitfalls” include high patient costs, high potential for over diagnosis, data sensitivities (legal, ethical) and time as evidence to support PMED use is still developing, as well as addressing disease co-morbidities that can significantly influence patient health outcomes and/or ongoing compliance. For PMED to realise its potential in human healthcare, equal consideration for addressing disease comorbidities, such as pain must be addressed. Pain today continues to represent a significant problem in both physician and patient centres. Current opioid use has had a long effective analgesic history but within the last decade, concerns have been raised over heightened abuse and toxicity profile suggesting a strong need for effective non-opioid analgesic alternatives.

 

SPEAKER

Dr. Sean Hall, Chief Executive Officer of Medlab
Chief Executive Officer
Dr. Sean Hall

Sean founded Medlab in August 2012; he has over 20 years' experience in nutraceutical sales and development, as well as early drug discovery in Australia, Asia and the US. Sean has led and inspired his teams to author multiple patents, write peer-reviewed articles and deliver lectures at scientific conferences. His passion is leading his researchers into novel areas and strong commercialisation opportunities.

Prior Sean was a founder of FIT-BioCeuticals. Under his management and guidance, BioCeuticals became the most innovative, research-driven, practitioner brand in Australia. For his sale of FIT-BioCeuticals to Blackmores in 2012, Sean was nominated as a finalist in the inaugural Australian Exit CEO of the Year Award. Sean is a Medical Doctor with an MBA in clinical pharmaceutical management and focuses on the research to pioneer innovation and commercialisation. Sean is an active member of Medicines Australia, the European Medical Association, the American Federation for Medical Researcher, The World Medical Association, A4M and Special Operations Medical Association.

COMMENTS 0

Tell us what you think login to share your thoughts.